Wednesday, February 10, 2010, 8:11pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Accelrys Inc. (ACCL)

At 5:00AM SGT: 6.01 USD   0.00 (0.00%)  
 MORE ON ACCL 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Accelrys, Inc. (NGM:ACCL) Delayed quote dataEdit
Last Trade:6.01 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:6.01
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:6.00
Day's Range:N/A - N/A
52wk Range:3.05 - 6.28
Volume:0
Avg Vol (3m):101,881
Market Cap:165.64M
P/E (ttm):120.20
EPS (ttm):0.05
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add ACCL to Portfolio   Download Data

 HEADLINES 
ACCELRYS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed 5:19am)
New Star Analyst Rankings for Accelrys, Inc.
StarMine (Sun, Feb 7)
ACCELRYS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Fri, Feb 5)
Accelrys Announces Third Quarter Fiscal Year 2010 Financial Results
Business Wire (Fri, Feb 5)
Accelrys to Showcase Integrated Informatics, Modeling and Simulation Solutions at the Molecular Medicine Tri-Conference
Marketwire (Fri, Jan 29)
Accelrys Announces Date of Third Quarter Fiscal 2010 Financial Results and Conference Call
Business Wire (Fri, Jan 29)
Accelrys to Showcase New Biotherapeutics Research Tools in Discovery Studio(R) at CHI's PepTalk 2010 Conference
Marketwire (Fri, Jan 8)
ACCELRYS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
EDGAR Online (Wed, Jan 6)
Accelrys Further Strengthens Management Team with Two Experienced Executives
Business Wire (Wed, Jan 6)
Accelrys to Showcase Materials Studio 5.0 at MRS (Materials Research Society) Fall Meeting
Marketwire (Wed, Nov 25)
More Headlines for ACCL...

 ANALYST 
EPS Est (next year) (Mar-10) :0.25
EPS Est (in 2 years) (Mar-11) :N/A
Avg Rec (current)*:2.0
PEG Ratio:0.86
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Accelrys, Inc. engages in the design, development, marketing, and support of software based solutions that facilitate the discovery and development of products and processes in the pharmaceutical, biotechnology, energy, chemical, aerospace and def...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices